Enanta Pharmaceuticals | Crediti Commerciali





Crediti Commerciali Cambiamento Data
AbbVie USD 12.77B 132M 2025-09
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 17.56B 1.32B 2025-09
BioCryst Pharmaceuticals USD 79.07M 6.61M 2024-12
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Gilead Sciences USD 5.1B 314M 2025-09
GlaxoSmithKline GBP 7.76B 545M 2025-12
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Immunic USD 1.5M 50K 2024-06
Incyte USD 1.02B 128.52M 2025-12
Insmed USD 65.26M 10.23M 2025-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Neurocrine Biosciences USD 728M 132.3M 2025-09
Novartis USD 8.98B 192M 2025-09
Novavax USD 94.96M 62.81M 2024-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Vertex Pharmaceuticals USD 1.95B 52.9M 2025-09


Enanta Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.